Advertisement

KIR in Type 1 Diabetes

Disparate Distribution of Activating and Inhibitory Natural Killer Cell Receptors in Patients Versus HLA-Matched Control Subjects

  1. Arno R. van der Slik1,
  2. Bobby P.C. Koeleman12,
  3. Willem Verduijn1,
  4. G. Jan Bruining3,
  5. Bart O. Roep1 and
  6. Marius J. Giphart1
  1. 1Department of Immunohaematology & Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands
  2. 2Department of Medical Genetics, University Medical Center, Utrecht, the Netherlands
  3. 3Department of Clinical Genetics, Sophia Children’s Hospital, Erasmus Medical Center, Rotterdam, the Netherlands
  1. Address correspondence and reprint requests to Bart O. Roep, Department of Immunohaematology & Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands. E-mail: boroep{at}lumc.nl

Abstract

Killer cell immunoglobulin-like receptors (KIRs) modulate natural killer cell and T-cell function by interacting with HLA class 1 ligands on target cells. Both KIR and HLA are highly polymorphic. We studied the influence of KIR and HLA class 1 genes on the susceptibility to develop type 1 diabetes. The results showed increased numbers of activating KIR genes in patients compared with control subjects (P = 0.049). The combination of the activating KIR2DS2 gene, together with its putative HLA ligand, was present more frequently in patients than in diabetes high-risk HLA-matched control subjects (P = 0.030). Moreover, our results imply that an increase in activating KIR2DS2-HLA ligand pairs combined with a lack of inhibitory KIR-HLA ligand pairs is associated with an additional risk to develop type 1 diabetes in individuals with diabetes high-risk HLA alleles (P = 0.035). We propose that the genetic imbalance between KIR and their HLA class 1 ligands may enhance the activation of T-cells with a low affinity for pancreatic self-antigens, thereby contributing to the pathogenesis of type 1 diabetes.

Footnotes

| Table of Contents
Advertisement